A peer-reviewed study of Mindbloom’s client treatment outcomes was revealed while in the Journal of Affective Disorders in 2022, titled Before completion of the very first RCT of recurring ketamine for PTSD, results ended up published from two preliminary studies of repeated ketamine treatment among the patients with treatment-resistant depression https://elenai555cre2.prublogger.com/profile